Dabrafenib and trametinib (combination) for ameloblastoma

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 11 Feb 2025: Trial registered, NCT06819605

The trials

NCT06819605: Neoadjuvant Therapy With Conservative Surgery vs. Up-front Conservative Surgery for BRAF V600E-Mutated Ameloblastoma

State
Not started
Phase
Phase 2 and Phase 3
People
46 planned
Started
1 Mar 2025
Primary completion
30 Oct 2028
Arms
Neoadjuvant group
Results
None posted
  1. 11 Feb 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.